This is great, but (obviously) not purely benevolent.
A vial of analog insulin costs something like $6-7 to produce, probably less at Walmart scale. The distribution costs probably make the net cost somewhere still in the $7-10 range.
That’s a $60-65 or ~90% margin per Vial.
5-10 million or so insulin users in the US, let’s assume Walmart captures 3 million, at 3 vials per month.
$180 * 12 * 3mil ~~ 6.5 Billion.
Current market cap 400B
Lots of assumptions, but Walmart may have just added 2% of market cap per annum by insulin sales?
A vial of analog insulin costs something like $6-7 to produce, probably less at Walmart scale. The distribution costs probably make the net cost somewhere still in the $7-10 range.
That’s a $60-65 or ~90% margin per Vial.
5-10 million or so insulin users in the US, let’s assume Walmart captures 3 million, at 3 vials per month.
$180 * 12 * 3mil ~~ 6.5 Billion.
Current market cap 400B
Lots of assumptions, but Walmart may have just added 2% of market cap per annum by insulin sales?